European Commission awards 12 million Euros to study zebrafish models for human development and disease.
The European Commission has awarded an unprecedented 12 million Euros for zebrafish research to a consortium of 15 European institutions, led by the Max Planck Institute for Developmental Biology.
The ZF-MODELS consortium hopes to establish zebrafish models for human diseases, discover genes that will lead to the identification of new drug targets and gain fundamental insights into human development.
The zebrafish, a popular aquarium fish, is ideally suited to study the fundamental processes underlying embryonic development and the genetic basis of diseases.
In recent years it has become one of the favourite model organisms of academic scientists and the biotech industry, and deciphering of its genome is already underway.
In the face of strong transatlantic competition, the European Commission has now decided to boost European zebrafish research by making it a flagship project of its 6th Framework Programme.
The Integrated Project, ZF-MODELS, will bring together 15 leading European research institutions (see list below).
Over five years, these institutions will receive a total budget of 12,400,000 Euros. 12,000,000 Euros will be contributed by the European Commission and 400,000 Euros by the Swiss National Science Foundation.
The partners of the ZF-MODELS project will join forces to work towards a common goal: to gain new insights into the genetic control of fundamental biological processes relevant for human disease, such as development, physiology and behaviour.
The results, they hope, will form a basis for the development of new or improved therapies.
Targets of the project will be common diseases such as cancer, neurodegenerative diseases, muscular dystrophies, eye diseases and behavioural disorders, as well as resistance to infections and wound healing.
To reach its aims the project will use advanced scientific tools that have only recently been developed by zebrafish researchers, and apply them on a massive scale and in an integrated fashion. Highlights of the project will include:
Mutagenesis projects that will bring together scientists from all over Europe to examine zebrafish carrying genetic mutations.
In addition to the mutants with defects in early development identified in previous projects, a focus will be on mutations that affect the adult fish, since these are of special interest for human diseases.
The analysis of the activity (expression) of tens of thousands of zebrafish genes on gene chips (microarrays) that will help to understand how they regulate each other's activity during normal development, and how this regulation is disturbed in mutants.
The generation of thousands of fish expressing Green Fluorescent Protein (GFP) controlled by the enhancer sequences of specific genes. Under UV light, tissues of these fish will light up indicating wherever the respective gene is active.
A facility to knock-out genes that will provide European researchers with zebrafish mutants for specific genes on demand. This will let them study genes of particular interest for which no mutant is found in the mutagenesis projects. The knock-out fish will be suitable as models for human diseases and the development of therapies.
A European zebrafish database that will integrate all project data in a three-dimensional anatomical atlas of zebrafish development, linked with the relevant gene activities. This database will be accessible through the project web site (zf-models) and will be open to scientists and the interested public world-wide.
The funding of the ZF-MODELS project by the European Commission comes at a crucial stage. The integration of the major European zebrafish labs in this project will further increase the competitive position of European zebrafish research.
The substantial funding granted to the project will allow the creation and integration of the necessary critical mass of multidisciplinary expertise and excellence needed to tackle the ambitious objectives of the project.
The project is coordinated by the Max Planck Institute for Developmental Biology in Tьbingen, Germany. Dr. Robert Geisler is the project's Scientific Coordinator, Dr. Ralf Dahm is the Project Manager and Nobel Laureate Prof. Christiane Nьsslein-Volhard chairs the project's Executive Committee.
The project officially began on January, 1st 2004 and will be kicked-off with a meeting of the partners to be held at the Max Planck Institute for Developmental Biology in Tьbingen from February, 14th-15th 2004.
Partners of ZF-MODELS Integrated Project
Max Planck Society for the Advancement of Science
Munich, Germany
Max Planck Institute for Developmental Biology
Tьbingen, Germany
Contact: Dr. Robert Geisler (Scientific Coordinator)
Phone: +49-7071-601443
Email: robert.geislertuebingen.mpg
Max Planck Institute of Molecular Cell Biology and Genetics
Dresden, Germany
Contact: Prof. Michael Brand
Phone: +49-351-2102514
Email: brandmpi-cbg
Max Planck Institute for Immune Biology
Freiburg, Germany
Contact: Dr. Matthias Hammerschmidt
Phone: +49-761-5108495
Email: hammerschmidimmunbio.mpg
Genome Research Ltd
The Wellcome Trust Sanger Institute
Cambridge, United Kingdom
Contact: Dr. Jane Rogers
Phone: +44-1223-494938
Email: jrhsanger.ac.uk
Institute de Gйnйtique et de Biologie Molйculaire et Cellulaire
Illkirch, France
Contact: Dr. Christine Thisse
Phone: +33-388-653360
Email: thisseigbmc.u-strasbg.fr
Hubrecht Laboratory, Netherlands Institute for Developmental Biology
Utrecht, The Netherlands
Contact: Prof. Ronald Plasterk
Phone: +31-30-2121963
Email: plasterkniob.knaw.nl
The University of Sheffield
Sheffield, United Kingdom
Contact: Prof. Philip Ingham
Phone: +44-114-2222710
Email: p.w.inghamsheffield.ac.uk
University College London
London, United Kingdom
Contact: Prof. Stephen Wilson
Phone: +44-20-76793348
Email: s.wilsonucl.ac.uk
Institut National de la Santй et de la Recherche Mйdicale
Paris, France
Contact: Dr. Frйdйric Rosa
Phone: +33-1-44323978
Email: rosawotan.ens.fr
Albert-Ludwigs-Universitдt Freiburg
Freiburg, Germany
Contact: Prof. Wolfgang Driever
Phone: +49-761-2032587
Email: drieverbiologie.uni-freiburg
University of Bergen
Bergen, Norway
Contact: Dr. Thomas Becker
Phone: +47-5-5584338
Email: tom.beckersars.no
Universita' degli Studi di Padova
Padova, Italy
Contact: Prof. Francesco Argenton
Phone: +39-49-8276229
Email: francesco.argentonunipd.it
GSF-National Research Center for Environment and Health
Neuherberg, Germany
Contact: Dr. Laure Bally-Cuif
Phone: +49-89-31873562
Email: ballygsf
Institut Pasteur
Paris, France
Contact: Dr. Philippe Herbomel
Phone: +33-1-44389529
Email: herbomelpasteur.fr
Leiden University
Leiden, The Netherlands
Contact: Prof. Herman Spaink
Phone: +31-71-5275055
Email: spainkrulbim.leidenuniv.nl
ETH - Swiss Federal Institute of Technology, Zurich
Zurich, Switzerland
Contact: Prof. Stephan Neuhauss
Phone: +41-1-6353288
Email: neuhausshifo.unizh.ch
Forschungszentrum Karlsruhe GmbH
Eggenstein-Leopoldshafen, Germany
Contact: Prof. Uwe Strдhle
Phone: +49-7247-823291
Email: uwe.straehleitg.fzk
Max Planck Society
for the Advancement of Science
Press and Public Relations Department
HofgartenstraЯe 8
D-80539 Munich
PO Box 10 10 62
D-80084 Munich
Phone: +49-89-2108-1276
Fax: +49-89-2108-1207
E-mail: pressempg-gv.mpg
Internet: mpg
Responsibility for content:
Dr. Bernd Wirsing (-1276)
Executive Editor:
Dr. Andreas Trepte (-1238)
Online-Editor:
Michael Frewin (-1273)
ISSN 0170-4656
Contact:
Dr. Ralf Dahm - Project Manager
Max Planck Institute for Developmental Biology, Tuebingen
Tel.: +49 7071 601-444
Fax: +49 7071 601-448
E-mail: ralf.dahmtuebingen.mpg
Комментариев нет:
Отправить комментарий